| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 15:18 | Eightco reports holding over 10% of circulating WLD supply | ||
| 15:18 | SMX expands rubber traceability platform to latex and rubber gloves | ||
| 15:18 | Sonim stockholders approve sale of rugged device business to NEXA | ||
| 15:18 | Axsome stock gets Buy rating from TD Cowen on FDA priority review | ||
| 15:18 | Needham reiterates Buy on Braze stock, names it top pick for 2026 | ||
| 14:30 | Vodafone settles contingent liability agreement with Vi | ||
| 14:30 | NANO Nuclear signs MOU with University of Illinois for microreactor | ||
| 14:30 | Delcath's HEPZATO shows consistent efficacy across patient subgroups | ||
| 14:30 | NANO Nuclear signs MOU for microreactor at University of Illinois | ||
| 14:30 | BLAQclouds to spin out property group with January distribution | ||
| 14:30 | Linamar completes €45 million acquisition of Georg Fischer's Leipzig plant | ||
| 14:30 | Nano Labs expands BNB holdings to $112 million, begins share buyback | ||
| 14:30 | FDA rejects Corcept's relacorilant for hypercortisolism hypertension | ||
| 14:30 | IWG launches $50 million share buyback program for 2026 | ||
| 14:30 | Tower Semiconductor stock rating downgraded by Wedbush on valuation | ||
| 14:30 | Freedom Capital Markets initiates Buy rating on International Bancshares stock | ||
| 14:30 | Praxis Precision Medicines stock gains as TD Cowen reiterates Buy on FDA breakthrough status | ||
| 14:30 | GlobalFoundries stock rating downgraded to Neutral by Wedbush | ||
| 13:54 | Profusa expands European footprint with French distributor partnership | ||
| 13:54 | Capstone extends revolving credit facility with Berkshire Bank | ||
| 13:42 | BMO Capital resumes WSP Global stock coverage with Outperform rating | ||
| 13:42 | MakeMyTrip stock rating reiterated at Overweight by Morgan Stanley | ||
| 13:42 | Morgan Stanley sees China's December PMI strength driven by exports and policy | ||
| 13:42 | H.C. Wainwright reiterates Buy rating on Bright Minds stock with $115 target | ||
| 13:42 | Raymond James reiterates Outperform rating on Inflarx stock at $9 target |